Synthesis and characterization of new Schiff base bearing bis(pyrano[3,2-c]quinolinone): Efficient cationic dye adsorption from aqueous solution

This review summarizes research advances in photocatalytic organic pollutant degradation in metal–organic frameworks. Efficient removal of organic pollutants from wastewater has become a hot research topic due to its ecological and environmental importance. Traditional water treatment methods such as adsorption, coagulation, and membrane separation suffer from high operating costs, and even generate secondary pollutants. Photocatalysis on semiconductor catalysts (TiO 2 , ZnO, Fe 2 O 3 , CdS, GaP, and ZnS) has demonstrated efficiency in degrading a wide range of organic pollutants into biodegradable or less toxic organic compounds, as well as inorganic CO 2 , H 2 O, NO 3 − , PO 4 3− , and halide ions. However, the difficult post-separation, easy agglomeration, and low solar energy conversion efficiency of these inorganic catalysts limit their large scale applications. Exploitation of new catalysts has been attracting great attention in the related research communities. In the past two decades, a class of newly-developed inorganic–organic hybrid porous materials, namely metal–organic frameworks (MOFs) has generated rapid development due to their versatile applications such as in catalysis and separation. Recent research has showed that these materials, acting as catalysts, are quite effective in the photocatalytic degradation of organic pollutants. This review highlights research progress in the application of MOFs in this area. The reported examples are collected and analyzed; and the reaction mechanism, the influence of various factors on the catalytic performance, the involved challenges, and the prospect are discussed and estimated. It is clear that MOFs have a bright future in photocatalysis for pollutant degradation.

In the present study, graphene oxide (GO) was used for the adsorption of anionic azo-dyes such as Acid Orange 8 (AO8) and Direct Red 23 (DR23) from aqueous solutions. GO was characterized by Fourier Transform-Infrared Spectroscopy (FTIR), X-ray Photoelectron Spectroscopy (XPS), Thermogravimetric Analysis (TGA), Atomic Force Microscopy (AFM), X-ray Diffraction (XRD), Scanning Electron Microscopy (SEM), High-Resolution Transmission Electron Microscopy (HRTEM) and zeta potential measurements. The influence of dye initial concentration, temperature and pH on AO8 and DR23 adsorption onto GO was investigated. Equilibrium data were analyzed by model equations such as Langmuir Freundlich, Temkin, Dubinin-Radushkevich and Redlich-Peterson isotherms and were best represented by Langmuir and Redlich-Peterson isotherm model. Kinetic adsorption data were analyzed using the pseudo-first-order kinetic model, the pseudo-second-order kinetic model and the intraparticle diffusion model. The adsorption kinetics well fitted using a pseudo-second-order kinetic model. Thermodynamics parameters, ΔG°, ΔH° and ΔS°, were calculated, indicating that the adsorption of AO8 and DR23 onto GO was spontaneous process. The adsorption process of AO8 onto GO was exothermic, while the adsorption of DR23 onto GO was endothermic in nature.

The advent of Camptothecin added a new dimension in the field anticancer drug development containing quinoline motif. Quinoline scaffold plays an important role in anticancer drug development as their derivatives have shown excellent results through different mechanism of action such as growth inhibitors by cell cycle arrest, apoptosis, inhibition of angiogenesis, disruption of cell migration, and modulation of nuclear receptor responsiveness. The anti-cancer potential of several of these derivatives have been demonstrated on various cancer cell lines. In this review we have compiled and discussed specifically the anticancer potential of quinoline derivatives, which could provide a low-height flying bird's eye view of the quinoline derived compounds to a medicinal chemist for a comprehensive and target oriented information for development of clinically viable anticancer drugs.